يعرض 1 - 10 نتائج من 50 نتيجة بحث عن '"Benzoxazinas"', وقت الاستعلام: 1.15s تنقيح النتائج
  1. 1
    رسالة جامعية

    المؤلفون: Gascó Catalán, Carolina

    مرشدي الرسالة: Guirado López, Gonzalo, Sebastián Pérez, Rosa M.

    المصدر: TDX (Tesis Doctorals en Xarxa)

    وصف الملف: application/pdf

  2. 2

    المؤلفون: Forchetti Casarino, Agustín

    المساهمون: Spontón, Marisa Elisabet, Martinelli, Marisa, Tomba, Juan Pablo, Inalbon, Cristina, Estenoz, Diana Alejandra

    المصدر: Biblioteca Virtual (UNL)
    Universidad Nacional del Litoral
    instacron:UNL

    وصف الملف: application/pdf

  3. 3
    دورية أكاديمية

    المساهمون: GESIDA-8314 Study Group, Troya,J, Solís,J Hospital Universitario Infanta Leonor, Madrid, Spain. Ribera,E Hospital Universitario Vall d’Hebrón, Barcelona, Spain. Podzamczer,D, Imaz,A Hospital Universitario de Bellvitge, Barcelona, Spain. Hontañón,V, González-García,J Hospital Universitario La Paz/IdiPAZ, Madrid, Spain. Terrón,JA Hospital Jerez de la Frontera, Jerez de la Frontera, Spain. Boix,V Hospital General Universitario de Alicante, Alicante, Spain. Moreno,S Hospital Universitario Ramón y Cajal, Madrid, Spain. Barrufet,P Hospital de Mataró, Mataró, Spain. Castaño,M, Berenguer,J Hospital Regional Universitario de Málaga, Málaga, Spain. Carrero,A Hospital Universitario Gregorio Marañón, Madrid, Spain. Galindo,MJ Hospital Clínico de Valencia, Valencia, Spain. Suárez-Lozano,I, Raffo,M Hospital Universitario Infanta Elena, Huelva, Spain. Knobel,H Hospital del Mar, Barcelona, Spain. Yllescas,M, Esteban,H Fundación SEIMCGESIDA, Madrid, Spain., The study was supported by ViiV Healthcare and SEIMC-GESIDA Foundation (grant number Gesida-8314).

    مصطلحات موضوعية: Benzoxazinas, Recuento de Linfocito CD4, Didesoxinucleósidos, Combinación de medicamentos, Efectos colaterales y reacciones adversas relacionados con medicamentos, Estudios de seguimiento, Tasa de filtración glomerular, Infecciones por Vih, VIH-1, Humanos, Análisis de intención de tratar, Lamivudine, Lípidos, Masculino, ARN, Estudios retrospectivos, Rilpivirine, Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Oxazines::Benzoxazines, Medical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Count::Blood Cell Count::Leukocyte Count::Lymphocyte Count::CD4 Lymphocyte Count, Medical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleosides::Deoxyribonucleosides::Dideoxynucleosides, Medical Subject Headings::Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinations, Medical Subject Headings::Diseases::Chemically-Induced Disorders::Drug-Related Side Effects and Adverse Reactions, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Follow-Up Studies, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Techniques, Urological::Kidney Function Tests::Glomerular Filtration Rate, Medical Subject Headings::Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections

    وصف الملف: application/pdf

    العلاقة: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0164455Test; Troya J, Ryan P, Ribera E, Podzamczer D, Hontañón V, Terrón JA, et al. Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study. PLoS ONE. 2016; 11(10):e0164455; http://hdl.handle.net/10668/2520Test; PMC5058546

  4. 4
    دورية أكاديمية

    المساهمون: Cohorte de Adultos de la Red de Investigación en SIDA, Spain., SPREAD Program, Hofstra,LM, Sauvageot,N, Struck,D, Schmit,JC Luxembourg Institute of Health, Luxembourg. Hofstra,LM, Wensing,AMJ Department of Virology, University Medical Center Utrecht, The Netherlands. Albert,J, Sönnerborg,A Karolinska Institute, Solna. Karolinska University Hospital, Stockholm, Sweden. Alexiev,I, Beshkov,D National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria. Garcia,F Complejo Hospitalario Universitario de Granada. Instituto de Investigación IBS Granada, Spain. Van de Vijver,DAMC, Boucher,CAB Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Åsjö,B University of Bergen, Norway. Coughlan,S University College Dublin, Ireland. Descamps,D AP-HP Groupe hospitalier Bichat-Claude Bernard. IAME INSERM UMR 1137. Université Paris Diderot Sorbonne Paris Cité, Paris, France. Griskevicius,A Lithuanian AIDS Center, Vilnius, Lithuania. Hamouda,O Robert Koch Institute, Berlin, Germany. Horban,A Hospital of Infectious Diseases, Warsaw, Poland. Van Kasteren,M St Elisabeth Hospital, Tilburg, The Netherlands. Kolupajeva,T Infectiology Center of Latvia, Riga. Kostrikis,LG University of Cyprus, Nicosia. Liitsola,K Department of Infectious Diseases, National Institute for Health and Welfare, Helsinki, Finland. Linka,M National Reference Laboratory for HIV/AIDS, National Institute of Public Health, Prague, Czech Republic. Mor,O National HIV Reference Laboratory, Chaim Sheba Medical Center, Tel-Hashomer, Israel. Nielsen,C Statens Serum Institut, Copenhagen, Denmark. Otelea,D National Institute for Infectious Diseases “Prof. dr. Matei Bals”, Bucharest, Romania. Paraskevis,D National Retrovirus Reference Center, University of Athens, Greece. Paredes,R IrsiCaixa Foundation, Badalona, Spain. Poljak,M Faculty of Medicine, Slovenian HIV/AIDS Reference Centre, University of Ljubljana, Slovenia. Puchhammer-Stöckl,E Medical University Vienna, Austria. Staneková,D Slovak Medical University, Bratislava, Slovakia. Stanojevic,M Faculty of Medicine, University of Belgrade, Serbia. Van Laethem,K Rega Institute for Medical Research, KU Leuven, Belgium. Zazzi,M University of Siena, Italy. Zidovec Lepej,S University Hospital for Infectious Diseases “Dr. Fran Mihaljevic”, Zagreb, Croatia., This work was supported by a CORE grant of Fond National de la Recherche Luxembourg (grant number C12/BM/4011111–HIV molecular epidemiology in Europe). This work has been partially supported by the European Commission (fifth framework, grant number QLK2-CT-2001-01344, sixth framework, grant number LSHP-CT-2006-518211, DynaNets grant number 233847, seventh framework, CHAIN grant number 223131), Belgium: Belgian AIDS Reference Laboratory Fund, Belgian Fonds voor Wetenschappelijk Onderzoek (grant number G.0692.14), Cyprus: Cyprus Research Promotion Foundation (grant number Health/0104/22), Denmark: Danish AIDS Foundation, France: Agence Nationale de Recherches sur le SIDA et les Hepatites Virales, Germany: Ministry of Health (grant number 1502-686-18), Ministry of Education and Research (grant number 01KI501), Italy: Fifth National Program on HIV/AIDS, Instituto Superiore di Sanità (grant numbers 40F.56 and 20D.1.6), Luxembourg: Fondation Recherche sur le SiDA and Ministry of Health, Republic of Serbia: Ministry of Education and Science (grant number 175024), Slovakia: project “Center of Excellence of Environmental Health,” ITMS number 26240120033, based on supporting operational research and development program financed from the European Regional Development Fund, and Sweden: Swedish Research Council and Swedish Civil Contingencies Agency.

    مصطلحات موضوعية: HIV-1, Drug resistance, Transmission, Antiretroviral therapy, Europe, Benzoxazinas, Intervalos de confianza, Resistencia a medicamentos, Europa (Continente), Infecciones por VIH, Mutación, Prevalencia, Inhibidores de proteasas, Salud pública, Inhibidores de la transcriptasa inversa, Rilpivirina, Encuestas y Cuestionarios, Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Oxazines::Benzoxazines, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Confidence Intervals, Medical Subject Headings::Geographicals::Geographic Locations::Europe, Medical Subject Headings::Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors, Medical Subject Headings::Disciplines and Occupations::Health Occupations::Medicine::Public Health, Medical Subject Headings::Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Drug Resistance, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Reverse Transcriptase Inhibitors

    وصف الملف: application/pdf; application/vnd.oasis.opendocument.text

    العلاقة: http://cid.oxfordjournals.org/content/62/5/655.abstractTest; Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, et al. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe. Clin. Infect. Dis. 2016; 62(5):655-63; http://hdl.handle.net/10668/2306Test; PMC4741360

  5. 5
    مؤتمر

    المساهمون: Estrada,V Infectious Diseases, Hospital Clínico San Carlos, Madrid, Spain. Monge,S, Sobrino,P Instituto de Salud Carlos III, Centro Nacional de Epidemiología, Madrid, Spain. Gómez-Garre,D Vascular Biology Lab, Hospital Clinico San Carlos, Madrid, Spain. Berenguer,J nfectious Diseases, Hospital General Gregorio Marañón, Madrid, Spain. Bernardino,JI Infectious Diseases, Hospital La Paz, Madrid, Spain. Santos,J Infectious Diseases, Hospital Virgen de la Victoria, Málaga, Spain. Moreno Zamora,A Infectious Diseases, Hospital Ramón y Cajal, Madrid, Spain. Martínez,E Infectious Diseases, Hospital Clinic, Barcelona, Spain. Blanco,JR Infectious Diseases, Hospital San Pedro-CIBIR, Logroño, Spain.

    وصف الملف: application/pdf

    العلاقة: http://www.jiasociety.org/index.php/jias/article/view/19544Test; Estrada V, Monge S, Gómez-Garre D, Sobrino P, Berenguer J, Bernardino JI, et al. Comparison of oxidative stress markers in HIV-infected patients on efavirenz or atazanavir/ritonavir-based therapy. J Int AIDS Soc. 2014; 17(4 Suppl 3):19544; http://hdl.handle.net/10668/1842Test; PMC4224902

  6. 6
    رسالة جامعية

    المؤلفون: Gascó, Carolina

    المساهمون: Guirado López, Gonzalo, Sebastián Pérez, Rosa M.

    وصف الملف: application/pdf

    العلاقة: Programa de Doctorat en Química; https://ddd.uab.cat/record/267062Test; urn:oai:ddd.uab.cat:267062; urn:oai:www.tdx.cat:10803/675767; urn:oai:egreta.uab.cat:studenttheses/86e7d2ea-b383-43ac-b087-487ffe71ddbd

  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية